Erin Colgan
SVP of Finance, Faeth Therapeutics, Inc.
Companies
- Faeth Therapeutics, Inc.Chief financial officer Feb 17, 2022 to Feb 16, 20241
- Faeth Therapeutics, Inc.SVP of Finance Feb 3, 2021 to Feb 5, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Faeth Therapeutics, Inc. FTH67,462 shares3$1.3M at $19.52Feb 15, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 15, 2024Shares withheld for tax 3,627 shares at $0.79 of Faeth Therapeutics, Inc.3
- Feb 15, 2023Granted 21,300 shares of Faeth Therapeutics, Inc.4
- Feb 15, 2023Granted 21,300 shares of Faeth Therapeutics, Inc.5
- Feb 15, 2023Granted 30,046 shares of Faeth Therapeutics, Inc.4
- Feb 15, 2023Granted 30,046 shares of Faeth Therapeutics, Inc.5
- Feb 15, 2023Shares withheld for tax 10,943 shares at $1.50 of Faeth Therapeutics, Inc.6
- Feb 15, 2022Granted 21,000 shares of Faeth Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Mar 29, 2023
- 5SEC EDGARForm 4 filed Feb 17, 2023
- 6SEC EDGARForm 4 filed Sep 11, 2023
- 7SEC EDGARForm 4 filed Feb 17, 2022